CV-19 vaccine designer joins AusBiotech 2021 line-up

In less than two weeks, global keynote Dr Barney Graham will join Australia’s biggest week in biotech to share his lessons learnt during the COVID-19 pandemic and offer insights on the future of vaccinology.

One of the ‘brains trust’ behind the design of Moderna’s COVID-19 vaccine, voted one of the world’s most influential individuals of 2021 by Time Magazine, and a multi award-winning US immunologist, virologist, and clinical trials physician, Dr Graham is the Former Deputy Director of the US NIAID Vaccine Research Center and a global thought leader on emerging viral diseases and pandemic preparedness.

Hosting a keynote of Dr Graham’s calibre demonstrates the importance and profile of Australian life sciences within our global ecosystem, and how the AusBiotech 2021 national conference provides a platform for learning and networking as we continue to celebrate our industry and champion advocacy in our mission to facilitate the global growth of our industry.

Dr Barney Graham is one of more than 100 national and international thought leaders delivering almost 30 sessions across five days at AusBiotech 2021, Australia’s premier life sciences conference.

AusBiotech 2021 keynote speakers include:

  • Dr Paul Stoffels, Executive Vice President, Chief Scientific officer, Johnson & Johnson: Past, Present and Future – a 10 year retrospective of Johnson & Johnson Innovation in Australia and a view to the next 10 years;
  • Millis Oration keynote Professor Sharon Lewin AO, The Peter Doherty Institute for Infection and Immunity: HIV to COVID-19: what history has taught us about our response to pandemics;
  • Howard Sachs, Siemens Ltd: Pharma 4.0: fast tracking discovery through to commercialisation;
  • Dr Niels Emmerich, Vice President and Global Head of Technology Search & Evaluation, AbbVie Inc: Current pharma models for accessing novel technologies: opportunities and challenges for biotechs and universities;
  • Professor Philip Hugenholtz, Co-Founder, Microba: The human health and microbiome connection – advances in methods to controlling human health and disease;
  • Dr Victoria Gordon, Managing Director and CEO, QBiotics: Changing the pace: Raising capital to accelerate programmes.

AusBiotech 2021 is dedicated to consolidating the sector’s growth, and the conference will once again present issues critical to industry; engage our strong network through the one-to-one business matching programme, an ‘Engage Hub’ to meet potential partners, and informal networking lounges; celebrate our life science leaders through the AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards 2021; and connect innovation with capital, with delegates also receiving access to Australia’s preeminent life science investment event Australia Biotech Invest & Partnering 2021.

The annual event brings together Australian and international biotech leaders and stakeholders. For more than three decades the national event has created a forum to reflect on the sector’s achievements and exchange ideas to further advance the sector’s standing both nationally and globally.

Secure your registration now and save up to $150; Late Registration rates begin on 14 October 2021.

Pitch, partner, engage and exchange – no matter where you are, as we unite to celebrate and champion Australia’s life sciences sector. AusBiotech 2021 is proudly sponsored by the Victorian Government.

/Public Release. This material from the originating organization/author(s) may be of a point-in-time nature, edited for clarity, style and length. The views and opinions expressed are those of the author(s).View in full here.